4-tert-Butyltoluene, also known as p-tert-butyltoluene, is an aromatic hydrocarbon with a tert-butyl group attached to the para position of the toluene ring. It is a colorless liquid with a characteristic aromatic odor. 4-tert-butyltoluene is primarily used as an intermediate in the production of various chemicals and materials. Its synthesis often involves Friedel-Crafts alkylation of toluene with tert-butyl chloride or isobutane in the presence of a Lewis acid catalyst. Due to its structural characteristics, 4-tert-butyltoluene exhibits interesting properties that make it a valuable compound in different fields. It is a component of some gasoline blends and is used as a solvent in various industrial processes. The presence of the tert-butyl group significantly influences the reactivity and physical properties of the molecule, making it a subject of study in organic chemistry and materials science.'
| ID Source | ID |
|---|---|
| PubMed CID | 7390 |
| CHEMBL ID | 1489547 |
| MeSH ID | M0089689 |
| Synonym |
|---|
| LS-13978 |
| 1-tert-butyl-4-methylbenzene |
| 4-tert-butyltoluene |
| 1-methyl-4-tert-butylbenzene |
| p-methyl-tert-butylbenzene |
| 4-tert-butyl-1-methylbenzene |
| wln: 1x1 & 1 & r d1 |
| p-tert-butyltoluene |
| nsc-6589 |
| toluene, p-tert-butyl- |
| 98-51-1 |
| benzene,1-dimethylethyl)-4-methyl- |
| 4-methyl-tert-butylbenzene |
| nsc6589 |
| inchi=1/c11h16/c1-9-5-7-10(8-6-9)11(2,3)4/h5-8h,1-4h |
| benzene, 1-(1,1-dimethylethyl)-4-methyl- |
| NCGC00091789-01 |
| p-t-butyltoluene |
| ccris 4762 |
| hsdb 5008 |
| nsc 6589 |
| p-tbt |
| ai3-26435 |
| 4-t-butyltoluene |
| einecs 202-675-9 |
| ptbt |
| 8-methylparacymene |
| brn 2038670 |
| benzene, 1-methyl-4-(1,1-dimethylethyl)- |
| 4-tert-butyltoluene, 95% |
| B0744 |
| AKOS000119946 |
| 1-(tert-butyl)-4-methylbenzene |
| A845869 |
| NCGC00091789-02 |
| 1-tert-butyl-4-methyl-benzene |
| tox21_303201 |
| cas-98-51-1 |
| dtxsid1024704 , |
| dtxcid404704 |
| NCGC00256994-01 |
| NCGC00259878-01 |
| tox21_202329 |
| 4-05-00-01097 (beilstein handbook reference) |
| unii-589519d43l |
| 589519d43l , |
| ec 202-675-9 |
| FT-0619516 |
| 4-t-butyltoluene [hsdb] |
| 1-(1,1-dimethylethyl)-4-methylbenzene |
| 1-methyl-4-(2-methyl-2-propanyl)benzene |
| CHEMBL1489547 |
| 4-t-butyl-1-methylbenzene |
| 4-tert-butyl toluene |
| p-tert.-butyltoluene |
| tert-butyl-4-methylbenzene |
| p-tert.butyltoluene |
| 1-methyl-4-tert-butyl benzene |
| p-t-butyl toluene |
| benzene, 1-methyl-4-tert-butyl- |
| 1-(1,1-dimethylethyl)-4-methyl-benzene |
| W-100078 |
| mfcd00008837 |
| 4-tertbutyltoluene |
| Z104474112 |
| Q20972145 |
| 4-|tert|-butyltoluene |
| EN300-19523 |
| F87411 |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 19.9526 | 0.0013 | 18.0743 | 39.8107 | AID926; AID938 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 36.9847 | 0.0002 | 29.3054 | 16,493.5996 | AID743069; AID743075 |
| activating transcription factor 6 | Homo sapiens (human) | Potency | 62.0221 | 0.1434 | 27.6121 | 59.8106 | AID1159516 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 36.4445 | 0.0003 | 23.4451 | 159.6830 | AID743066; AID743067 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 3.0638 | 0.0006 | 27.2152 | 1,122.0200 | AID743202 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 21.8224 | 0.0023 | 19.5956 | 74.0614 | AID651631 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (34.03) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (10.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (90.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||